Literature DB >> 11312112

Neuropilin in the midst of cell migration and retraction.

S Soker1.   

Abstract

Neuropilin (NRP) is a 140 kDa membrane protein, with a large extracellular domain and a short cytoplasmic tail, that was isolated in 1987 from the optic tactum of Xenopus laevis. About 10 years after its isolation, NRP was identified as a receptor for semaphorin, a family of axonal chemorepellent proteins and for vascular endothelial growth factor (VEGF), a family of potent angiogenic factors. In the nervous system, NRP forms a high affinity semaphorin-binding complex with a receptor tyrosine kinase, plexin, that mediates semaphorin-induced growth cone collapse. On the endothelium, NRP is expressed together with KDR, a VEGF receptor tyrosine kinase. We have shown that NRP potentiated KDR-mediated endothelial cell migration and proliferation. Some tumor cells can express high levels of NRP, which is typically their only VEGF receptor, but do not seem to respond to VEGF directly. Possible use of NRP as a target for VEGF antagonists, in the context of antiangiogenic therapy, are described.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312112     DOI: 10.1016/s1357-2725(01)00028-0

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

1.  Targeted therapies in the management of colorectal carcinoma: role of bevacizumab.

Authors:  Ajithkumar Puthillath; Anush Patel; Marwan G Fakih
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

2.  Identification of two novel alternatively spliced Neuropilin-1 isoforms.

Authors:  Frank C Cackowski; Li Xu; Bo Hu; Shi-Yuan Cheng
Journal:  Genomics       Date:  2004-07       Impact factor: 5.736

3.  VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival.

Authors:  Piotr Religa; Renhai Cao; Dorota Religa; Yuan Xue; Nenad Bogdanovic; David Westaway; Hugo H Marti; Bengt Winblad; Yihai Cao
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

4.  Inhibiting PHD2 in bone marrow mesenchymal stem cells via lentiviral vector-mediated RNA interference facilitates the repair of periodontal tissue defects in SD rats.

Authors:  Changxing Chen; Houxuan Li; Jun Jiang; Qian Zhang; Fuhua Yan
Journal:  Oncotarget       Date:  2017-08-14

5.  Anti-neuropilin-1 monoclonal antibody suppresses the migration and invasion of human gastric cancer cells via Akt dephosphorylation.

Authors:  Yuan Ding; Juan Zhou; Shengyu Wang; Yue Li; Yanjun Mi; Shihua Gao; Yun Xu; Yuqiang Chen; Jianghua Yan
Journal:  Exp Ther Med       Date:  2018-05-30       Impact factor: 2.447

6.  Systematic profiling of alternative splicing events and splicing factors in left- and right-sided colon cancer.

Authors:  Xiaoliang Huang; Jungang Liu; Xianwei Mo; Haizhou Liu; Chunyin Wei; Lingxu Huang; Jianhong Chen; Chao Tian; Yongsheng Meng; Guo Wu; Weishun Xie; Franco Jeen P C; Zujun Liu; Weizhong Tang
Journal:  Aging (Albany NY)       Date:  2019-10-04       Impact factor: 5.682

7.  Human adipose-derived stem cells enriched with VEGF-modified mRNA promote angiogenesis and long-term graft survival in a fat graft transplantation model.

Authors:  Fei Yu; Nevin Witman; Dan Yan; Siyi Zhang; Meng Zhou; Yan Yan; Qinke Yao; Feixue Ding; Bingqian Yan; Huijing Wang; Wei Fu; Yang Lu; Yao Fu
Journal:  Stem Cell Res Ther       Date:  2020-11-19       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.